EVALUATION OF THE EFFECTIVENESS OF ANTIRETROVIRAL THERAPY FOR KEY POPULATIONS INFECTED WITH HIV/AIDS IN UKRAINE AND WORLDWIDE
DOI:
https://doi.org/10.32782/2306-2436.14.2.2024.313Keywords:
antiretroviral therapy; HIV/AIDS; stigma; Ukraine; review.Abstract
Abstract. Background. Antiretroviral therapy (ART) is the cornerstone in the fight against HIV/AIDS, enabling an increase in life expectancy among patients. Evaluating its effectiveness across different population groups is critically important for monitoring the dynamics of disease progression and improving treatment strategies. Materials and Methods. The study materials included official data from the Public Health Center of the Ministry of Health of Ukraine, WHO statistics on the prevalence of HIV/AIDS, and an analysis of scientific articles indexed in PubMed that address the topic and describe the situation in different regions of the world. The methods applied in the study included sociological surveys, literature reviews, comparative analysis, statistical analysis, and information synthesis. Results. A survey of 543 respondents from various age groups and regions of Ukraine showed that only 32% had a clear understanding of what ART is and its capabilities, while 43% had heard about ART but did not understand its meaning. Additionally, 25% of respondents had never heard of ART. Access to ART was significantly higher in urban areas, reaching 85%. The effectiveness of ART was evident in most cases: 85% of respondents reported a substantial reduction in viral load within the first six months, 70% noted improvements in overall well-being, and 15% experienced side effects. Globally, ART awareness varies across regions. For instance, in the United States, awareness levels range between 75% and 80% in central regions. In India, awareness levels reach 65% to 70%, while in Southern Africa, they stand at 70%, compared to just 35% to 40% in Central Africa. Accessibility rates closely align with awareness levels across these regions. However, in countries such as India and parts of Africa, stigma remains a significant obstacle to accessing ART. Conclusions. ART can be considered the most effective method for combating HIV/AIDS, provided that treatment is timely and all guidelines are followed. However, despite this, the level of awareness remains low, especially in suburban areas and among younger populations. Access to ART is directly proportional to the economic and social development of a region, with barriers such as stigma hindering free access to treatment.
References
1. Антиретровірусна терапія (АРТ). Центр громадського здоров’я України. МОЗ. URL: https://phc.org.ua/kontrolzakhvoryuvan/ vilsnid/statistika-z-vilsnidu/antiretrovirusnaterapiya- art.
2. Adaptive HIV pre-exposure prophylaxis adherence interventions for young women in Johannesburg, South Africa: a sequential multiple-assignment randomised trial. J. Velloza et al. The lancet HIV. 2024. URL: https://doi.org/10.1016/ s2352-3018(24)00268-6.
3. A qualitative study on the burden of nonadherence to antiretroviral therapy among people living with HIV/AIDS in Jharkhand, India. M. Kumar et al. Cureus. 2024. URL: https:// doi.org/10.7759/cureus.73636.
4. Development of a city-wide rapid antiretroviral therapy initiation toolkit for people newly diagnosed with HIV in the Southern United States. A.C. Pettit et al. Open forum infectious diseases. 2024. URL: https://doi.org/10.1093/ofid/ofae660.
5. Evaluation of treatment outcomes among individuals on highly active antiretroviral therapy in Kwazulu‐Natal, South Africa. T.W. Muzumbukilwa et al. AIDS research and treatment. 2024. Vol. 2024, no. 1. URL: https://doi.org/10.1155/arat/8834740.
6. Fostering healthy cognitive ageing in people living with HIV. L.A. Cysique et al. The lancet HIV. 2024. URL: https://doi.org/10.1016/s2352-3018(24)00248-0.
7. Gengiah T.N., Abdool Karim Q. Preventing HIV in young women in Africa. The lancet HIV. 2024. URL: https://doi.org/10.1016/s2352-3018(24)00309-6.
8. Springer S.A. Plans to end HIV should address substance use. The lancet HIV. 2024. Vol. 11, no. 12. P. e792–e793. URL: https://doi.org/10.1016/s2352-3018(24)00297-2.
9. Tlhaku K., Dorward J. Improving quality of interpersonal care in HIV programmes. The lancet HIV. 2024. URL: https://doi.org/10.1016/s2352-3018(24)00311-4.
10. WHO implementation tool for monitoring the toxicity of new antiretroviral and antiviral medicines in HIV and viral hepatitis programmes. World Health Organization (WHO). URL: https://www.who.int/publications/i/item/who-implementationtool- for-monitoring-the-toxicity-of-new-antiretroviral-andantiviral- medicines-in-hiv-and-viral-hepatitis-programmes.
11. World health statistics 2024: monitoring health for the SDGs, sustainable development goals. World Health Organization (WHO). URL: https://www.who.int/publications/i/item/9789240094703.